PubRank

Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling (2012/52)

Clinical Trial ID NCT02407327

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02407327

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009 46.35
2 Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004 27.92
3 Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 2009 21.94
4 Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008 13.54
5 Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res 2004 5.23
6 Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011 4.72
7 HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A 2004 3.43
8 Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995 2.75
9 Molecular biomarker analyses using circulating tumor cells. PLoS One 2010 2.38
10 Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method. Int J Cancer 2011 1.97
11 Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 2010 1.85
12 Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor. Clin Cancer Res 2007 1.84
13 Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells. Clin Cancer Res 2010 1.65
14 EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res 2010 1.50
15 Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer. Neoplasia 2008 1.25
16 M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin Cancer Res 2010 1.17
17 Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br J Cancer 2012 0.93
18 Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions. Oncology 2009 0.85
19 Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients. J Cancer Res Clin Oncol 2010 0.80
Next 100